Editor’s Note: Welcome to “Let's Chat,” a blog series featuring contributions from members of the ophthalmic community. These blogs are an opportunity for ophthalmic bloggers to engage with readers with about a topic that is top of mind, whether it is practice management, experiences with patients, the industry, medicine in general, or healthcare reform. The views expressed in these blogs are those of their respective contributors and do not represent the views of Ophthalmology Times or UBM Medica.
Watching the fishmongers at Seattle’s Pike Place Market, I’m fascinated by the exuberance and skill they show for catching a huge salmon flying through the air. As an educator, I sometimes think of the fishmongers’ skill when I help colleagues firmly grip the slippery fish that is dry eye.
Educational weekends with plenty of hands-on modules help break down the barriers to clinical implementation of dry eye knowledge, but the pace and quantity of content can make attendees feel like I’m throwing them a great many fish, one after the other. They can feel overwhelmed. This is completely understandable, given the seemingly exponential growth in the number of technologies and therapeutics available for our dry eye patients.
I want my colleagues to see that there is an easy antidote to feeling overwhelmed. The key is to maintain a sense of clinical and intellectual curiosity. I’d like to share why dry eye spurs my curiosity, and why I think being a “dry eye sleuth” is refreshing (yes, refreshing) in today’s medical practice environment.
Laura M. Periman, MD, is Ocular Surface Disease Expert and Director of Dry Eye Services and Clinical Research at Evergreen Eye Center in Seattle, WA. She discloses relationship with Allergan, Bruder, BioTissue, Eyedetec, Lumenis, Science Based Health, Shire, Sun, TearLab and Visant. Follow her on Twitter at @DryEyeMaster.
1. Belmonte C, Nichols JJ, Cox SM, et al. TFOS DEWS II pain and sensation report. Ocul Surf. 2017;15:404-437.
2. Rothrock NE, Hays RD, Spritzer K, Yount SE, Riley W, Cella D. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol. 2010;63:1195-204.